Page last updated: 2024-08-17

propionamide and Chronic Disease

propionamide has been researched along with Chronic Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asari, T; Fujimori, Y; Fushimi, N; Inoue, T; Isaji, M; Kobayashi, M; Kurooka, T; Nishibe, H; Onozato, T; Takeda, H; Takemura, M1

Other Studies

1 other study(ies) available for propionamide and Chronic Disease

ArticleYear
Mizagliflozin, a novel selective SGLT1 inhibitor, exhibits potential in the amelioration of chronic constipation.
    European journal of pharmacology, 2017, Jul-05, Volume: 806

    Topics: Amides; Animals; Chronic Disease; Clinical Trials, Phase I as Topic; Constipation; Dietary Fiber; Dogs; Dose-Response Relationship, Drug; Glucosides; Humans; Loperamide; Male; Pyrazoles; Rats; Sodium-Glucose Transporter 1

2017